These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35586977)

  • 1. PP2 protects from keratin mutation-associated liver injury and filament disruption via SRC kinase inhibition in male but not female mice.
    Li P; Maitra D; Kuo N; Kwan R; Song Y; Tang W; Chen L; Xie Q; Liu L; Omary MB
    Hepatology; 2023 Jan; 77(1):144-158. PubMed ID: 35586977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding.
    Kwan R; Chen L; Looi K; Tao GZ; Weerasinghe SV; Snider NT; Conti MA; Adelstein RS; Xie Q; Omary MB
    Hepatology; 2015 Dec; 62(6):1858-69. PubMed ID: 26126491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury.
    Ku NO; Soetikno RM; Omary MB
    Hepatology; 2003 May; 37(5):1006-14. PubMed ID: 12717381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deacetylation via SIRT2 prevents keratin-mutation-associated injury and keratin aggregation.
    Sun J; Li P; Gui H; Rittié L; Lombard DB; Rietscher K; Magin TM; Xie Q; Liu L; Omary MB
    JCI Insight; 2023 Jul; 8(14):. PubMed ID: 37485877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation.
    Harada M; Strnad P; Resurreccion EZ; Ku NO; Omary MB
    Hepatology; 2007 Jan; 45(1):88-96. PubMed ID: 17187412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoskeletal keratin glycosylation protects epithelial tissue from injury.
    Ku NO; Toivola DM; Strnad P; Omary MB
    Nat Cell Biol; 2010 Sep; 12(9):876-85. PubMed ID: 20729838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of caspase-digestion sites in keratin 18 interferes with filament reorganization, and predisposes to hepatocyte necrosis and loss of membrane integrity.
    Weerasinghe SV; Ku NO; Altshuler PJ; Kwan R; Omary MB
    J Cell Sci; 2014 Apr; 127(Pt 7):1464-75. PubMed ID: 24463813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratin overexpression levels correlate with the extent of spontaneous pancreatic injury.
    Toivola DM; Nakamichi I; Strnad P; Michie SA; Ghori N; Harada M; Zeh K; Oshima RG; Baribault H; Omary MB
    Am J Pathol; 2008 Apr; 172(4):882-92. PubMed ID: 18349119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies.
    Ku NO; Strnad P; Zhong BH; Tao GZ; Omary MB
    Hepatology; 2007 Nov; 46(5):1639-49. PubMed ID: 17969036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation.
    Snider NT; Weerasinghe SV; Iñiguez-Lluhí JA; Herrmann H; Omary MB
    J Biol Chem; 2011 Jan; 286(3):2273-84. PubMed ID: 21062750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratin mutation predisposes to mouse liver fibrosis and unmasks differential effects of the carbon tetrachloride and thioacetamide models.
    Strnad P; Tao GZ; Zhou Q; Harada M; Toivola DM; Brunt EM; Omary MB
    Gastroenterology; 2008 Apr; 134(4):1169-79. PubMed ID: 18395095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein phosphatase inhibition in normal and keratin 8/18 assembly-incompetent mouse strains supports a functional role of keratin intermediate filaments in preserving hepatocyte integrity.
    Toivola DM; Omary MB; Ku NO; Peltola O; Baribault H; Eriksson JE
    Hepatology; 1998 Jul; 28(1):116-28. PubMed ID: 9657104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of a major keratin phosphorylation site predisposes to hepatotoxic injury in transgenic mice.
    Ku NO; Michie SA; Soetikno RM; Resurreccion EZ; Broome RL; Omary MB
    J Cell Biol; 1998 Dec; 143(7):2023-32. PubMed ID: 9864372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratin 8/18 Regulate the Akt Signaling Pathway.
    Lim Y; Kim S; Yoon HN; Ku NO
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratin-8 null mice have different gallbladder and liver susceptibility to lithogenic diet-induced injury.
    Tao GZ; Toivola DM; Zhong B; Michie SA; Resurreccion EZ; Tamai Y; Taketo MM; Omary MB
    J Cell Sci; 2003 Nov; 116(Pt 22):4629-38. PubMed ID: 14576356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratin 8/18 modulation of protein kinase C-mediated integrin-dependent adhesion and migration of liver epithelial cells.
    Bordeleau F; Galarneau L; Gilbert S; Loranger A; Marceau N
    Mol Biol Cell; 2010 May; 21(10):1698-713. PubMed ID: 20357007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratin impact on PKCδ- and ASMase-mediated regulation of hepatocyte lipid raft size - implication for FasR-associated apoptosis.
    Gilbert S; Loranger A; Omary MB; Marceau N
    J Cell Sci; 2016 Sep; 129(17):3262-73. PubMed ID: 27422101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of genetic variants of keratins 8 and 18 in patients with drug-induced liver injury.
    Usachov V; Urban TJ; Fontana RJ; Gross A; Iyer S; Omary MB; Strnad P;
    BMC Med; 2015 Aug; 13():196. PubMed ID: 26286715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human keratin 8 variants promote mouse acetaminophen hepatotoxicity coupled with c-jun amino-terminal kinase activation and protein adduct formation.
    Guldiken N; Zhou Q; Kucukoglu O; Rehm M; Levada K; Gross A; Kwan R; James LP; Trautwein C; Omary MB; Strnad P
    Hepatology; 2015 Sep; 62(3):876-86. PubMed ID: 25963979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity.
    Zhong B; Strnad P; Selmi C; Invernizzi P; Tao GZ; Caleffi A; Chen M; Bianchi I; Podda M; Pietrangelo A; Gershwin ME; Omary MB
    Hepatology; 2009 Aug; 50(2):546-54. PubMed ID: 19585610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.